Home
Our Business
Public Equity
In May 2017, EG Capital Advisors launched a new public equities fund. EG Life Sciences Fund 1 invests in public biotech companies at the clinical testing stage with a focus on gene and cell therapy technologies. The Fund invests in companies developing and commercialising innovative and vital healthcare products, services and technologies; and delivers venture capital-style upside potential with public market liquidity.

Please request further information by submitting your request to ir@egcapitaladvisors.com.